Definium’s Second Phase 3 Win Puts LSD Closer to FDA Review for Anxiety
Definium Therapeutics has reported a second positive Phase 3 trial of its LSD-based treatment for generalized anxiety disorder, strengthening the ...
Definium Therapeutics has reported a second positive Phase 3 trial of its LSD-based treatment for generalized anxiety disorder, strengthening the ...
Psychedelics.media delivers trusted news, intelligence, and insights for the global psychedelic medicine industry.
